Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,602 |
| Other current assets | 509 |
| TOTAL | $2,111 |
| Non-Current Assets | |
| PPE Net | 2,986 |
| Other Non-Current Assets | 255 |
| TOTAL | $3,241 |
| Total Assets | $4,448 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 473 |
| Accrued Expenses | 476 |
| TOTAL | $1,561 |
| Non-Current Liabilities | |
| Long Term Debt | 325 |
| TOTAL | $579 |
| Total Liabilities | $2,140 |
| Shareholders' Equity | |
| Retained earnings | -26,113 |
| Other shareholders' equity | 27,513 |
| TOTAL | $2,308 |
| Total Liabilities And Equity | $4,448 |